West-Ward Pharmaceutical Corporation recalls Fentanyl Citrate Inj., USP, CII, 250 mcg/5 mL (50 mcg/mL) (0.05 mg/mL) 25 x 5 mL Single Dose Vials, For Intravenous or…
- Recall date
- February 16, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0420-2015
- FDA classification
- Class III
- Brand / firm
- West-Ward Pharmaceutical Corporation
- Sold / distributed
- Nationwide
Why it was recalled
Failed Impurities/Degradation Specifications; 12 month stability testing.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Fentanyl Citrate Inj., USP, CII, 250 mcg/5 mL (50 mcg/mL) (0.05 mg/mL) 25 x 5 mL Single Dose Vials, For Intravenous or Intramuscular Use, Preservative Free, Rx Only, Manufactured by: West-Ward Pharmaceuticals, Eatontown, NJ 07724, NDC 0641-6028-25.
Get recall alerts
Free email alert whenever West-Ward Pharmaceutical Corporation has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: West-Ward Pharmaceutical Corporation